US Stock MarketDetailed Quotes

GILD Gilead Sciences

Watchlist
  • 82.810
  • +0.420+0.51%
Close Sep 13 16:00 ET
  • 82.470
  • -0.340-0.41%
Post 19:53 ET
103.10BMarket Cap100.99P/E (TTM)

Gilead Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q2
Stock NameRevenueRatio
Biktarvy3.23B46.48%
Other815M11.72%
Descovy485M6.97%
Sofosbuvir/Velpatasvir476M6.84%
Genvoya440M6.33%
Yescarta414M5.95%
Trodelvy320M4.60%
Odefsey315M4.53%
Vemlidy243M3.49%
Veklury214M3.08%
View all
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States19.44B71.68%
Europe4.31B15.89%
Other international3.37B12.42%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Cancer Research
Cancer Research
Intraday+0.43%
Mpox (monkeypox)
Mpox (monkeypox)
Intraday+0.40%
CAR-T Therapy
CAR-T Therapy
Intraday+0.37%